000 | 01075 a2200265 4500 | ||
---|---|---|---|
005 | 20250517032321.0 | ||
264 | 0 | _c20160808 | |
008 | 201608s 0 0 eng d | ||
022 | _a1874-4702 | ||
024 | 7 |
_a10.2174/1874467208666150507093258 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSoldatov, Nikolai M | |
245 | 0 | 0 |
_aCACNB2: An Emerging Pharmacological Target for Hypertension, Heart Failure, Arrhythmia and Mental Disorders. _h[electronic resource] |
260 |
_bCurrent molecular pharmacology _c2015 |
||
300 |
_a32-42 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Intramural | ||
650 | 0 | 4 |
_aArrhythmias, Cardiac _xdrug therapy |
650 | 0 | 4 |
_aCalcium Channels, L-Type _xdrug effects |
650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 |
_aMental Disorders _xdrug therapy |
773 | 0 |
_tCurrent molecular pharmacology _gvol. 8 _gno. 1 _gp. 32-42 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/1874467208666150507093258 _zAvailable from publisher's website |
999 |
_c24893447 _d24893447 |